Pregnancy phthalate metabolite concentrations and infant birth weight by gradations of maternal glucose tolerance |
| |
Authors: | Nudrat Noor Kelly K. Ferguson John D. Meeker Ellen W. Seely Russ Hauser Tamarra James-Todd Thomas F. McElrath |
| |
Affiliation: | 1. Departments of Environmental Health and Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, 02115, USA;2. Epidemiology Branch, National Institute of Environmental Health Sciences, Research Triangle Park, NC, 27709, USA;3. Department of Environmental Health Sciences, University of Michigan School of Public Health, Ann Arbor, MI, 48109, USA;4. Division of Endocrine, Diabetes, and Hypertension, Brigham and Women''s Hospital and Harvard Medical School, Boston, MA, 02115, USA;5. Division of Maternal Fetal Medicine, Brigham and Women''s Hospital and Harvard Medical School, Boston, MA, 02115, USA;6. Division of Women''s Health, Department of Medicine, Connors Center for Women''s Health and Gender Biology, Brigham and Women''s Hospital and Harvard Medical School, Boston, MA, 02115, USA |
| |
Abstract: | BackgroundHigher birth weight is an important adverse outcome associated with hyperglycemia in pregnancy. Recent studies suggest that phthalate exposure is associated with elevated glucose levels in pregnant women, with implications for higher birth weight in the offspring. No study to date has investigated the association between prenatal phthalate exposure on infant high birth weight accounting for the range of pregnancy glucose levels.MethodsA total of 350 women participating in an ongoing pregnancy cohort had data available on urinary phthalate metabolite concentrations at up to four time points across pregnancy. Urinary phthalate metabolites were averaged across pregnancy and log-transformed, specific gravity-adjusted and analyzed in quartiles. Birth weight was examined continuously (in grams), as well as dichotomized as large for gestational age (>90th percentile). Glucose levels were assessed based on Results from 50-g glucose challenge tests as a part of screening for gestational diabetes conducted at 24–28 weeks gestation, and grouped into 3 categories <120?mg/dL, 120–<140?mg/dL and ≥140?mg/dL. Multivariable linear regression was performed, adjusting for potential confounders in the overall population and stratified by pregnancy glucose levels.ResultsApproximately 20% of infants born to women with glucose levels ≥140?mg/dL were large for gestational age. Average mono-ethyl phthalate (MEP) concentrations were higher among women who had glucose levels ≥140?mg/dL (geometric mean 140.9?μg/L; 95% CI: 91.6–216.8); however, higher MEP concentrations were not associated with higher birth weight. When stratified by maternal glucose levels, there was a suggestive association between higher concentrations of mono-(3-carboxypropyl) phthalate (MCPP) and higher birth weight among women with glucose levels ≥140?mg/dL (adj. birth weight: 569.2?g; 95% CI: 14.1, 1178.2).ConclusionsHigher urinary phthalate metabolite concentrations were not significantly associated with higher birth weight. Counter to our hypothesis, women with higher glucose levels and higher urinary phthalate metabolites did not deliver babies with higher birth weight. |
| |
Keywords: | Phthalates Pregnancy Birth weight Large for gestational age Maternal obesity Maternal glucose |
本文献已被 ScienceDirect 等数据库收录! |
|